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Epigenetics plays a pivotal role in modulating gene response to physiological or 
pathological stimuli.
Histone Deacetylase inhibitors (HDACi) have been used in the treatment of vari-
ous cancers1, are effective in several animal models of neurodegenerative diseases, 
including amyotrophic lateral sclerosis (ALS), and are currently in clinical trial to pro-
mote muscle repair in muscular dystrophies2. However, long-term use of pan-HDAC 
inhibitors is not tolerated3. The assignment of distinct biological functions to individ-
ual HDACs in skeletal muscle is a prerequisite to improve the efficacy of pharma-
cological treatments based on HDACi. HDAC4 is a member of class II HDACs that 
mediates many cellular responses. Clinical reports suggest that inhibition of HDAC4 
can be beneficial to cancer cachexia, dystrophic or ALS patients. All the above condi-
tions are characterized by progressive muscle wasting and up-regulation of HDAC4 
expression in skeletal muscle, suggesting a potential role for this protein in regulat-
ing these diseases. To study the role of HDAC4 with a genetic approach, we gener-
ated several models of muscle disease in mice lacking HDAC4 in skeletal muscle: 
cancer cachexia, by implanting Lewis lung carcinoma (LLC), muscular dystrophy, by 
using mdx mice, or ALS, by using SODG93A mice. Lack of HDAC4 worsens skeletal 
muscle atrophy induced by both LLC and ALS, demonstrated by a reduction in mus-
cle mass and myofibers size. Conversely, dystrophic mice lacking HDAC4 in skele-
tal muscle show an increased number of necrotic myofibers and run less efficiently 
than mdx mice. The aggravation of the dystrophic phenotype may be partially due to 
the impairment in skeletal muscle regeneration observed in mice lacking HDAC4 in 
skeletal muscle. Our results indicate that HDAC4 is necessary for maintaining skel-
etal muscle homeostasis and function. Current studies aim to investigate the molec-
ular mechanisms underlying the role of HDAC4 in skeletal muscle maintenance in 
response to cancer cachexia, ALS or muscular dystrophy.
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